G&L Scientific is delighted to announce the appointment of Dr Ivan Fisher as Vice President, Regulatory Affairs.
Ivan has successfully and consistently made a direct and sustained contribution to the global regulatory conformance of numerous multinational Pharmaceutical, Consumer Healthcare and Generic companies over his 14 years within the regulatory affairs consulting arena.
Combining a strongly client-centric approach with strategic and critical-thinking skills and an ability to communicate clearly and effectively, Ivan has steadily garnered a reputation within the industry as an accomplished and trusted leader.
“We are both delighted and excited that Ivan is joining G&L Scientific. Having previously worked with him for over a decade, I have no doubt that his progressive approach is perfectly suited to help drive our newly-announced regulatory affairs service,” said CEO of G&L Scientific, Stephen Loughrey.
Mr. Loughrey added, “The fact that G&L was able to attract and secure such a talented and well-respected individual speaks volumes for the reputation of our company for delivering world-class services.”